AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04696263 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Da Vinci ® Xi system - MP Robotic Radical Prostatectomy
Description: After pneumoperitoneum is established, four 8mm, one 12 mm, and one 5 mm trocars are placed for instrumentation. After the robot is docked, radical prostatectomy is performed with the SOC approach.
Study NCT04696263 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Da Vinci ® SP system - SP Robotic Radical Prostatectomy
Description: After induction of general anesthesia and supine participant positioning, a 3.5 cm infraumbilical incision will be made for single-port access into the space of Retzius. Radical prostatectomy is then performed with the SOC approach
Study NCT04649476 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Camrelizumab
Description: The participants will receive camrelizumab (200 mg) intravenous infusion each 2-week cycle for 3 cycles prior to surgery.
Study NCT04649476 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Camrelizumanb plus TPF
Description: The participants will receive camrelizumab (200 mg) through intravenous infusion each 2-week cycle, and docetaxel (T) 75 mg/m2, cisplatin (P) 75 mg/m2, 5-Fluorouracil (F) 750 mg/m2 through intravenous infusion each 3-week cycle for 2 cycles.
Study NCT05166499 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Hydroxy Methyl Butyrate
Description: Hydroxy Methyl Butyrate
Study NCT05166499 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: OTHER
Intervention: Balanced Amino Acids
Description: Balanced Amino Acids
Study NCT06285318 — intervention group
Intervention type: OTHER
Intervention: Teclistamab
Description: No Intervention will be administered during the study. Retrospective data analysis using participants medical records collected within this study will be entered into CRF.
Study NCT06285318 — intervention group
Intervention type: OTHER
Intervention: Talquetamab
Description: No Intervention will be administered during the study. Retrospective data analysis using participants medical records collected within this study will be entered into CRF.
Study NCT06422273 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tranexamic Acid
Description: Endobronchial (topical) tranexamic acid used prophylactically prior to performing transbronchial biopsies in lung transplant recipients
Study NCT06422273 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Saline (placebo)
Description: Topical Saline (placebo) administered as endobronchial topical application prior to performing transbronchial biopsies in lung transplant recipients.
Study NCT05652335 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JNJ-79635322
Description: JNJ-79635322 will be administered as SC injection.
Study NCT05116241 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: BPZE1 pertussis vaccine and placebo
Description: Live attenuated pertussis vaccine and placebo
Study NCT05116241 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: BPZE1 pertussis vaccine and Boostrix
Description: Live attenuated pertussis vaccine and tetanus, diphtheria, and aP vaccine
Study NCT05116241 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Placebo and Boostrix
Description: Tetanus, diphtheria, and aP vaccine and placebo
Study NCT06031415 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GS-0272
Description: Administered subcutaneously (for Part A) Administered intravenously or subcutaneously (for Part B)
Study NCT06031415 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Administered subcutaneously (for Part A) Administered intravenously or subcutaneously (for Part B)
Study NCT05966532 — intervention group
Intervention type: BEHAVIORAL
Intervention: Hot Cognitive Task
Description: 1. Emotion processing:~   * Participants will be shown a series of faces that appear quickly and be asked to identify what emotion is shown.~  * Participants will be shown a face of an emotion and indicate if participant can see the emotion changing.~  * Participant will be shown a series of emotions and asked to respond to only a specific emotion.~2. Motivation reward and processing:~   * Participant will play with a simulated roulette and make a bet to evaluate their decision-making behavior.~  * Participant will be shown colored circles and choose the one more likely to win money.~3. Impulsivity:~   • Participant will be shown a series of stimuli where they will be asked to respond to the correct stimulus.~4. Social cognition:~   * Participant will be shown a series of moral situations in which a character is accidentally or intentionally harmed and be asked to rate the degree of guilt from the perspective of the victim or perpetrator.
Study NCT05966532 — intervention group
Intervention type: BEHAVIORAL
Intervention: Cold cognitive tasks
Description: * Montreal Cognitive Assessment (MoCA) - This will ask participants questions related to their cognition such as visuospatial skills, naming, memory, attention, language, and recall.~* Measurement of Everyday Cognition (ECog) - This scale will ask participants about their everyday memory, language, visuospatial ability, organization, and divided attention.~* Test of Premorbid Function (TOPF) - This test will evaluate memory performance and abilities of stud participants before onset pre-morbid status.~* California Verbal Learning Test -3rd Edition (CVLT-3) -This test will measure verbal learning and memory of study participants.~* Three tests from the Delis-Kaplan Executive Function System (D-KEFS; Verbal Fluency, Color-Word Interference, and Tower Tests). -These measures assess word finding and problem-solving ability.
Study NCT05966532 — intervention group
Intervention type: OTHER
Intervention: Structural magnetic resonance imaging (sMRI)
Description: This is a non-invasive procedure to assess the structure and function of participant's brain. Structural neuroanatomical data will be acquired using structural magnetic resonance. Imaging (sMRI) with the University of Texas Southwestern (UTSW) 3T (three Tesla field) MRI scanner. Prior to participation, the investigator's team will screen participant's to ensure eligibility to participate in the sMRI scan.
Study NCT05966532 — intervention group
Intervention type: OTHER
Intervention: Magnetoencephalography imaging (MEG)
Description: This is a non-invasive procedure to measure participant's brain activity. Participants will be sitting inside the machine in a chamber, with more space than a traditional MRI machine. A hat will be placed on top of participant's head which records their brain activity. Resting-state and task-based MEG recordings will occur in a three-layer magnetically shielded room (MSR) following our UTSW Advanced Neuroscience Imaging Research (ANSIR) established procedures. Before the scan, five coils will be secured to participant's head and a three-dimensional (3D) digitizer will be used to map the location of the coils, fiducials, and scalp surface. During recording, an electric current with a unique frequency label (i.e., 320 Hz) will be fed to each coil, which will permit real time head location tracking and subsequent offline head motion correction.
Study NCT05966532 — intervention group
Intervention type: BEHAVIORAL
Intervention: four self-report forms per the requirement of the NIH Common Data Elements project
Description: 1) DSM-5 Level 1 Cross Cutting Symptom Measure - Adult Report; a measure of multiple psychiatric symptoms, 2) Generalized Anxiety Disorder-7 (GAD-7; a measure of anxiety symptom severity), 3) Patient Health Questionniare-9 (PHQ-9; a measure of depression symptom severity), and 4) World Health Organization Disability Assessment Scale-2.0 (WHODAS-2.0; a measure of overall general functional status)
Study NCT05966532 — intervention group
Intervention type: BEHAVIORAL
Intervention: Four self-report measures to assess interpersonal functioning
Description: 1) Social Adjustment Scale - Self-report Short Form (SAS-SR: Short), 2) Inventory of Interpersonal Problems (IIP-64), 3) Social Network Index (SNI), 4) Interpersonal Support Evaluation List - 12 Items (ISEL-12).
Study NCT05966532 — intervention group
Intervention type: BEHAVIORAL
Intervention: Clinical assessments
Description: A Demographic and a Medical History Form will be completed. The Mini International Neuropsychiatric Interview (MINI-7.0 for DSM-5) is a structured psychiatric interview that will confirm presence of MDD and any exclusionary neuropsychiatric disorders. To measure depression symptoms/severity, primarily we will use the Clinician Rated Inventory of Depressive Symptomatology (IDS-C), Menstrual history and pregnancy tests for female participants.
Study NCT05966532 — intervention group
Intervention type: OTHER
Intervention: ATHF
Description: Psychotropic medication use/ treatment resistance level will be measured/documented with the Antidepressant Treatment History Form-Short-Form (ATHF-SF)
Study NCT05124704 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 5-8ml 0.375% ropivacaine
Description: 5-8ml of 0.375% ropivacaine depend on the height and weight of the patient was administrated through the epidural catheter at least 20 min before induction in experimental group. Followed by a continuous infusion of 4-6 ml/h using micro-infusion pump after induction during surgery.
Study NCT05124704 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: 5-8ml normal saline
Description: 5-8ml of normal saline depend on the height and weight of the patient was administrated through the epidural catheter at least 20 min before induction. Followed by a continuous infusion of 4-6 ml/h using micro-infusion pump after induction during surgery.
Study NCT06099457 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: SIB-Time web-application tool
Description: Parent-child dyads will use the SIBTime app in an 8-week intervention to test its relevance, acceptability, cultural appropriateness, and potential for efficacy.
Study NCT05612880 — intervention group
Intervention type: DRUG
Intervention: androgen receptor signaling inhibitors
Description: Prior to or within 8 weeks of ARSI initiation, men with advanced prostate cancer will perform baseline testing, with follow ups at 12 and 24 weeks
Study NCT06563154 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Exercise Capacity Assessment
Description: To examine the relationship between exercise capacity and physical fitness of dyslipidemia patients and quality of life, cognitive status and health literacy.
Study NCT06563154 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Physical Fitness Assessment
Description: * 1-Minute Sit-to-Stand Test: Participants will be asked to sit down and stand up for 1 minute without pausing, and the repetition number will be recorded.~* Timed Up-and-Go Test: Participants will be asked to get up, walk a distance of 3 meters, return and sit down again. The time spent during this track will be recorded.~* Peripheral muscle strength assessment: Participants will be asked to resist the resistance by producing maximum isometric force during the movement, and the maximal force will be evaluated with a dynamometer. The quadriceps femoris muscle, shoulder abductor muscles and hand grip strength will be used for the assessment.~* Flexibility assessment: Participants will be asked to reach towards the tips of their toes while sitting. During this time, the distance between the participant's fingertips and toes will be measured.
Study NCT06563154 — intervention group
Intervention type: OTHER
Intervention: Quality of Life Assessment
Description: Participants' quality of life will be assessed with the Turkish version of the Short Form Quality of Life Questionnaire (SF-36). The questionnaire consists of 36 questions that examine quality of life from different perspectives. It examines quality of life in the subcategories of physical function, physical role difficulty, pain, general health, vitality (energy), social function, emotional role difficulty and mental health. The score for each category varies between 0-100, with a high score indicating a good quality of life.
Study NCT06563154 — intervention group
Intervention type: OTHER
Intervention: Physical Activity Assessment
Description: Participants' physical activity level will be assessed with the Turkish version of the International Physical Activity Scale - Short Form (IPAQ-SF). The IPAQ-SF evaluates the physical activities of the participants in the last 7 days based on sitting time, walking time, moderate and vigorous physical activities.
Study NCT06563154 — intervention group
Intervention type: OTHER
Intervention: Cognitive Health Assessment
Description: Participants' cognitive health will be assessed with the with the Turkish version of the Mini Mental State Examine (MMSE). The test is scored between 0-30. Scores of 25 and above are considered normal. A total score of less than 10 indicates severe impairment. Scores between 10-19 indicate moderate dementia. Scores between 19-24 indicate early dementia.
Study NCT06563154 — intervention group
Intervention type: OTHER
Intervention: Health Literacy Assessment
Description: Participants' health literacy will be assessed with the Turkish version of the HLS-EU-47 health literacy survey. The survey consists of 47 questions. Each item is assessed with one of the following options: Very difficult (1), difficult (2), easy (3), very easy (4) and I don't know. A high total score indicates good health literacy. A total score of 0-25 points indicates insufficient health literacy, >25-33: problematic - limited health literacy, >33-42: sufficient health literacy, >42-50: excellent health literacy.
Study NCT05732792 — intervention group
Intervention type: OTHER
Intervention: CIPS Survey
Description: The survey is endorsed by the European Society of Anaesthesiology and Intensive Care (ESAIC) and will be distributed from February 2023 onwards to its members for a period of 3 months.~Each anesthesiologist's participation to the survey will be voluntary and anonymous individual consent will be implied by the person's willingness to complete the survey.~The survey will also mention this.~All surveys will be administered via SurveyMonkey. Surveymonkey allows to build Health Insurance Portability and Accountability Act (HIPAA) compliant surveys that follow strict rules around the protection of health information.~Of note, Surveymonkey is also GDPR (General Data Protection Regulation) compliant.~Data gathered from the questionnaires will be safely stored on the surveymonkey database. The access to the result database is held by a password that only the authors can use to analyze the data yielded at the end of the survey period.
Study NCT05526846 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Plant-based diet education
Description: Participants will receive weekly emails with information about plant-based diets and a goal/task for each week.~There will be a 'core curriculum' that will be sent to all participants, as well as additional information according to the participant's stage of change and food choice preferences.~All information will be available on a website that will be created for this study. The website will feature curated information about plant-based diets, that is tailored to patients who had recent colorectal operations and may have a colostomy or an ileostomy.
Study NCT05338918 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mental Imagery with Virtual Reality Training
Description: Mental Imagery TASK Practice with Virtual Reality Training: 30-40 minutes treatment sessions will be performed three times a week for six weeks, Part 1: 2-3 minutes of relaxation Part 2: Visual Imagery (external motor imagery training) for 5-8 minutes Part 3: Actual Task Practice for 10 minutes Part 4: Virtual Reality based training (including games for lower limb functions) for 10 minutes Part 5:Task Oriented training for 10 minutes Tasks for both (mental imagery + actual task practice) will be: Sit-stand task, Static stance (30 seconds), Indoor walk on a leveled surface, Walk indoor towards target, Forward / Side Stepping, Walking outdoors
Study NCT05338918 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Virtual Reality Training
Description: Virtual Reality Training: 30-40 minutes treatment sessions will be performed three times a week for six weeks. Games will include River rush, 20000 water leaks, reflex ridge along with task oriented training. Tasks will be: Sit-stand task, Static stance (30 seconds), Indoor walk on a leveled surface, Walk indoor towards target, Forward / Side Stepping, Walking outdoors
Study NCT05797233 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Anti-CD19 and anti-CD20 bicistronic CAR T- cells
Description: 0.66x10\^6 CAR+ T - 10x10\^6 CAR+ T cells/kg (weight based dosing per cohort) infused on day 0
Study NCT05797233 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: 500 mg/m\^2 IV infusion over 30 minutes on days -5, -4 and -3
Study NCT05797233 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine
Description: 30 mg/m\^2 IV infusion over 30 minutes administered immediately following the cyclophosphamide on days -5, -4,and -3
Study NCT04923581 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Oral Health Behavioral Interventions
Description: The study will use a factorial design to evaluate the efficacy of three distinct intervention components: Motivational interviewing, storytelling videos and oral health promotion messages, in enhancing mothers' brushing of their preschool children's teeth using fluoridated toothpaste.
Study NCT04965155 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Isatuximab-dexamethasone
Description: Isatuximab 10 mg/kg IV: 1,8,15 and 22 at cycle 1; days 1 and 15 at cycles 2-3 Dexamethasone 40 mg OS: 1,8,15 and 22 at cycle 1; days 1 and 15 at cycles 2-3
Study NCT05573477 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ATB-1011
Description: Oral tablet
Study NCT05573477 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ATB-1011
Description: Oral tablet
Study NCT05573477 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ATB-1012
Description: Oral tablet
Study NCT05573477 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ATB-1012
Description: Oral tablet
Study NCT05573477 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ATB-1013
Description: Oral tablet
Study NCT05573477 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ATB-1011 placebo
Description: Placebo matched to ATB-1011
Study NCT05573477 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ATB-1011 placebo
Description: Placebo matched to ATB-1011
Study NCT05573477 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ATB-1012 placebo
Description: Placebo matched to ATB-1012
Study NCT05573477 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ATB-1013 placebo
Description: Placebo matched to ATB-1013
Study NCT05097989 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ALXN2050
Description: Oral tablets
Study NCT05097989 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Oral tablets
Study NCT05437575 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ketamine Hydrochloride
Description: ketamine hydrochloride 2.5mg/ml packaged in pre-filled syringe
Study NCT05437575 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fentanyl Citrate
Description: fentanyl citrate 10mcg/ml packaged in pre-filled syringe
Study NCT05738005 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Tracking Dietary/Supplement Intake on MyFitnessPal smartphone application (app)
Description: Amyloidosis patients will use MyFitnessPal application to track dietary intake and use of herbal/alternative supplements in from week 2-9. Patient's usage of the application and questionnaires completed by the patient at the start, Week 2 and Week 10 will determine feasibility.
Study NCT06194409 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Echocardiography, Urine analysis , blood culture
Description: All patients will be investigated by ECG, Urine analysis, blood culture , Echocardiography
Study NCT04966143 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: LY011
Description: Targeting CLDN 18.2 Car-T injection
Study NCT06212479 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: MRI Scan
Description: Whole Body MRI Scan
Study NCT05030896 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Invasive treatment and exercise therapy
Description: The subjects of experimental group will perform therapeutic exercise program and they will be receive Percutaneous Electrolysis therapy and the subjects of experimental group will perform the same exercise program and they will be receive only needling puncture
Study NCT04075916 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Epclusa
Description: All patients will receive 12 weeks of sofosbuvir/velpatasvir as per the FDA label.
Study NCT05573477 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ATB-1013 placebo
Description: Placebo matched to ATB-1013
Study NCT06180317 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual reality
Description: Participants will view a specific relaxing and distracting scenario using virtual reality (VR) for approximately 7-8 minutes from one minute before the procedure until the end of the procedure. Assessment will be performed with STAI and VAS just before the endometrial biopsy procedure, VAS during the procedure and again with STAI and VAS after the procedure.
Study NCT04811560 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bleximenib
Description: Bleximenib is administered orally.
Study NCT05335447 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GLPG3667 capsule
Description: On Day 1, participants will receive a single oral dose of GLPG3667
Study NCT05335447 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: [14C]-GLPG3667 solution for infusion
Description: On Day 1, participants will receive a single microtracer microdose of \[14C\]-GLPG3667 as an intravenous infusion
Study NCT06246734 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Hasbro Joy for All robot pet companion
Description: The robot pets are stuffed animals (dogs and cats) that have features that make them seem lifelike. For example, the animal toys turn their heads when petted, purr or make puppy sounds, feel warm, have a heartbeat, and go to sleep when they are ignored. They respond to attention and petting like a real pet. The robot pets do not collect information and do not require any maintenance, except a battery. Engagement with the device is at the discretion of participants.